CD40LG and coinfection: This diagnostic shift may introduce challenges in differentiating active from resolved infections, underscoring the limitations of IgM ELISA in early CHIKV and DENV-CHIKV coinfection detection, thus emphasizing the need for molecular diagnostics to improve case identification accuracy.